Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T2* Cardiac MRI Screening of Highly Transfused Patients With Myelodysplastic Syndrome

NCT00749372 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT00749372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00749372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T2* Cardiac MRI Screening of Highly Transfused Patients With Myelodysplastic Syndrome
Lead sponsor
Weill Medical College of Cornell University
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2008
Completion date
March 29, 2013
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome (mds)